+++
name = "CPAG-1"
structure = "/img/structures/CPAG-1.png"
target = "PGRMC2"
activity = "Gain-of-function ligand"
pubchem_cid = "132274146"
cas = "2094991-62-3"
systematic_name = "(S)-2-butyramido-4-methyl-N-(naphthalen-2-yl)pentanamide"
synonyms = ["CGP201727"]
molecular_weight = "326.44"


[[references]]
authors_list = "Galmozzi, A., Kok, B. P., Kim, A. S., Montenegro-Burke, J. R., Lee, J. Y., Spreafico, R., Mosure, S., Albert, V., Cintron-Colon, R., Godio, C., Webb, W. R., Conti, B., Solt, L. A., Kojetin, D., Parker, C. G., Peluso, J. J., Pru, J. K., Siuzdak, G., Cravatt, B. F., Saez, E."
title = "PGRMC2 is an intracellular haem chaperone critical for adipocyte function"
journal = "Nature"
year = "2019"
volume = 576
pages = "138-142"
doi_link = "https://dx.doi.org/10.1038/s41586-019-1774-2"
pubmed_link = "https://www.ncbi.nlm.nih.gov/pubmed/31748741"

[[references]]
authors_list = "Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F."
title = "Ligand and Target Discovery by Fragment-Based Screening in Human Cells"
journal = "Cell"
year = "2017"
volume = 168
pages = "527-541.e29"
doi_link = "https://doi.org/10.1016/j.cell.2016.12.029"
pubmed_link = "https://www.ncbi.nlm.nih.gov/pubmed/28111073"
+++

CPAG-1 is an active analog of <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> which promoted adipogenesis in 3T3-L1s and hMSCs (human mesenchymal stem cells). CPAG-1 lacks the photoreactive and clickable groups present in <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> and dose-dependently competed <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> (10 µM) labeling of overexpressed PGRMC2 in HEK293T cells.

Treatment of diet-induced obese (DIO) mice with CPAG-1 (45 mg⋅kg−1) had no effect on weight or food intake, but treated mice had reduced fasting glycemia and insulin levels and improved glucose tolerance and insulin sensitivity Brown adipose tissue (BAT) histology showed decreased lipid content and an increase in multilocular adipocytes, features indicative of improved function. Histology of epididymal white adipose tissue (WAT) revealed a marked improvement in CPAG-1-treated mice, with fibrosis and inflammation noticeably decreased.